Updates in Thrombosis Management: The Emerging Role of Factor XI Inhibition

Updates in Thrombosis Management: The Emerging Role of Factor XI Inhibition

The goal of this activity is for learners to be better able to recognize current unmet needs in anticoagulation for thrombosis and understand the potential role of factor XI inhibitors.

  • Provider:Medscape, LLC
  • Activity Link: https://www.medscape.org/viewarticle/1000806
  • Start Date: 2024-05-16 05:00:00
  • End Date: 2024-05-16 05:00:00
  • Credit Details: IPCE Credits: 0.25 hours
    AMA PRA Category 1 Credit™️: 0.25 hours
    Nursing: 0.25 hours
    Pharmacy: 0.25 hours
  • Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 21982.0 - Is Kind Support: False Source: Janssen (Any division) - Amount: 23729.0 - Is Kind Support: False
  • Activity Type: Other/Blended Learning
  • CME Finder Type: Other
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.